See also this year's filing and all EDGAR filings for this company.
PDF Report 0001341235_2019_Aldeyra_Therapeutics_Inc.pdf
Logs
| warning | Ignoring company because Expenses is zero | pre-agg | {'balance_sheet': {'company_id': '0001341235', 'EntityCommonStockSharesOutstanding': 27395425, 'Assets': 95091155, 'AssetsCurrent': 94769286, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 8473176, 'LiabilitiesAndStockholdersEquity': 95091155, 'LiabilitiesCurrent': 8473176, 'LiabilitiesNoncurrent': 0, 'NetIncome': -38893245, 'PropertyPlantAndEquipmentNet': 235225, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 86644, 'remainder_ComprehensiveNetIncome': 8607, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 86617979, 'remainder_NetIncome': -38893245, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001341235')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Edgar->Model Mapping
